News Releases

Date	Title
05/16/2022	Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting
05/09/2022	Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
05/03/2022	Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
04/05/2022	Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference
03/25/2022	Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care
03/17/2022	Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
03/02/2022	Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
02/28/2022	Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates
02/22/2022	Heron Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022

Keyword Search